Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

16.8K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.8K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

10.4K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
10.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progress in Thymic Malignancy Care: The Imperative for Global Standards and Collaboration.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

A Response to the Letter to the Editor: "Is It Time to Move Beyond Linear Measurements Toward Volumetric Assessment in Thymic Tumors?"

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Striving for an Enhanced Tumor Classification System: Reflections on Cancer, Prognosis, Human Nature and Reality.

Clinical lung cancer·2026
Same author

A viable human lung cancer tissue collection (LCTC) to accelerate translational research.

Cancer treatment and research communications·2026
Same author

Managing Thymic Malignancies in 2025: Migrating from Masaoka to TNM.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Ninth Edition of the Tumor, Node, and Metastasis Classification of Lung Cancer.

Seminars in respiratory and critical care medicine·2025

Related Experiment Video

Updated: Apr 11, 2026

Characterization of Thymic Settling Progenitors in the Mouse Embryo Using In Vivo and In Vitro Assays
08:56

Characterization of Thymic Settling Progenitors in the Mouse Embryo Using In Vivo and In Vitro Assays

Published on: June 9, 2015

8.9K

What's new in thymic neoplasms.

Alberto Antonicelli1, Frank Detterbeck

  • 1Department of Surgery, Division of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut, USA.

Current Opinion in Pulmonary Medicine
|May 29, 2015
PubMed
Summary

Recent advancements in thymic malignancies are highlighted, driven by the International Thymic Malignancy Interest Group (ITMIG). This global collaboration has established standardized definitions, classifications, and a robust database, fostering significant research progress.

More Related Videos

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

12.8K
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.7K

Related Experiment Videos

Last Updated: Apr 11, 2026

Characterization of Thymic Settling Progenitors in the Mouse Embryo Using In Vivo and In Vitro Assays
08:56

Characterization of Thymic Settling Progenitors in the Mouse Embryo Using In Vivo and In Vitro Assays

Published on: June 9, 2015

8.9K
Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

12.8K
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.7K

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pathology

Background:

  • Thymic malignancies have seen limited progress over decades.
  • Recent years have witnessed transformative developments in the field.

Purpose of the Study:

  • To review major advancements in thymic malignancies over the past five years.
  • To highlight the role of the International Thymic Malignancy Interest Group (ITMIG) in driving progress.

Main Methods:

  • Establishment of ITMIG, a global collaborative network.
  • Development of a comprehensive international database for thymic malignancies.
  • Revision of histologic classification and introduction of a formal staging system.

Main Results:

  • ITMIG has fostered a worldwide community dedicated to thymic malignancies.
  • An extensive global database is under active analysis.
  • Standardized definitions, revised histology, and a new staging system facilitate collaboration.
  • Clinical trials and innovative research are being implemented.

Conclusions:

  • Clinicians and researchers must be aware of the resources and structure provided by ITMIG.
  • ITMIG offers a platform for collaboration and continued advancement in thymic malignancy research.